Liberia

STARAFRICA.COM                                                                                 April 30, 2015

ABUJA, Nigeria  --Governments in West Africa should improve health governance by scaling up investments in health infrastructure and human capital to ensure proactive responses against pandemics such as Ebola, a panel of discussants on Ebola has recommended.

A statement by the ECOWAS Commission on Thursday in Abuja said that the panelists at the debate on “Ebola; one year after,” organized by the Friedrich Ebert Stiftung (FES) in Abuja on Tuesday, explained that such investments would engender effective preventive and preparedness initiatives and also address the weak health systems of countries in the region, which suffered the heaviest burden of the latest Ebola Virus Disease (EVD) outbreak...

In particular, they recommended that public education and sensitization as well as community mobilization, participation and vigilance must be sustained until the disease is totally eliminated. There should also be effective psycho-social support and reintegration programmes for survivors and children orphaned by the disease....

Read complete story.

SCI DEVELOPMENT NET                                                                                April 29, 2015
(includes links to five feature stories and editorials on communication issues and other subjects.)
The outbreak of Ebola that has affected West Africa since December 2013 is the largest to date, with enormous human and economic costs. It has also exposed weaknesses in the global response system, including the handling of communication and complex social responses. What can we learn from this to better manage future health emergencies?

This Spotlight presents an in-depth analysis including opinions, facts and figures, and key resources. It features commentary by Sylvie Briand of the WHO, Rosamund Southgate of Médecins Sans Frontières and Annie Wilkinson of the Institute of Development Studies. 

It includes first-hand accounts by researchers with experience in the field, and interviews with social science expert Melissa Leach and communications managers at Médecins Sans Frontières-UK and BBC Media Action.
Read complete articles.

ASSOCIATED PRESS by Maria Cheng                                                        April 28, 2015

LONDON — The World Health Organization says it aims to identify and isolate all new Ebola cases in West Africa by the end of May to stop the spread of the lethal virus before the rainy season.

In a new Ebola plan released on Tuesday, the U.N. health agency said it hopes to limit transmission of the virus to the coastal areas of Guinea, Liberia and Sierra Leone before the rainy season begins, normally in April or May.

WHO said the decline in Ebola's spread has "plateaued," partly due to "persistently high transmission" in Guinea and Sierra Leone. Officials say the rainy season will make it more difficult for responders to reach remote areas....

BUSINESS STANDARD                                                                        April 27, 2015

HYDERABAD, India --Ella Foundation, which has taken up research for finding a potential vaccine for the deadly Ebola virus, today said it had successfully completed preliminary studies on the virus, which was responsible for high fatalities among humans in central Africa.

The Hyderabad-based foundation said it had completed the preliminary animal (with mice) experiments of the virus' glycoprotein with the targeted adenovirus, and the "immune response results have been good", which would be followed by toxicology tests and the subsequent clinical trials involving human beings.

Adenoviruses are responsible for respiratory infections, gastroenteritis, cystitis, and primary pneumonia in humans, and are therefore used as a clear target to understand the human immunity characteristics in laboratory. However, the efficacy of the vaccine is judged by the outcomes seen in human trials.

Read complete story.

http://www.business-standard.com/article/current-affairs/ella-foundation-announces-key-outcomes-in-ebola-vaccine-research-115042700631_1.html